Author:
Gold Ralf,Schneider-Gold Christiane
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Clinical Neurology,Pharmacology
Reference35 articles.
1. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330: 1797–1810.
2. Hohlfeld R, Wekerle H. The immunopathogenesis of myasthenia gravis. In: Engel AG, editor. Myasthenia gravis and myasthenic syndromes. Oxford: Oxford University Press;1999. pp. 87–110.
3. Vincent A, Bowen J, Newsom-Davis J, McConville J. Seronegative generalised myasthenia gravis: clinical features, antibodies and their targets. Lancet Neurol 2003;2: 99–106.
4. Hohlfeld R, Melms A, Schneider C, Toyka KV, Drachman DB. Therapy of myasthenia gravis and myasthenic syndromes In: Brandt T, Caplan LR, Dichgans J, Diener HC, Kennard C, editors. Neurological disorders: course and treatment. Philadelphia: Elsevier; 2003. pp. 1341–1362.
5. Wekerle H, Ketelsen UP. Intrathymic pathogenesis and dual genetic control of myasthenia gravis. Lancet 1977;1: 678–680.
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献